Impact Awards are grants from the Parkinson's Foundation that fund early-career independent investigators pursuing innovative research on Parkinson's disease. Awards provide $200,000 over two years ($100,000 per year) to support high-potential research ideas that need initial resources to demonstrate feasibility and attract future funding.

Eligible applicants must hold a PhD or MD and be in a tenure-track or equivalent faculty position; international applicants are welcome. The program is designed to bring together experts and generate new solutions to key clinical and scientific challenges in Parkinson's disease. Applicants can review program details, eligibility criteria, and deadlines through the Foundation's online portal.

Awards for Independent Investigators | Parkinson's Foundation The Parkinson’s Foundation offers competitive awards for independent investigators, including the Stanley Fahn Junior Faculty Award and Impact Awards. These programs fund early-career faculty, support high-potential research ideas that need initial resources and bring experts together to solve key clinical and scientific challenges.

Investigators can review program details, eligibility and deadlines online and explore all previously funded projects through the Foundation’s award database . The Parkinson's Foundation offers competitive awards for independent investigators: Stanley Fahn Junior Faculty Award : a three-year award providing a total of $300,000.

Impact Awards : funding for innovative projects that are in need of support to see their maximum impact on the Parkinson's community. Conference Awards : supporting the gathering of experts in the field working to address unsolved clinical or basic science problems relevant to Parkinson's.

Stanley Fahn Junior Faculty Award The Stanley Fahn Junior Faculty Award honors longtime Parkinson’s Foundation Scientific Director Stanley Fahn, MD, renowned for his clinical abilities and commitment to training the next generation of Parkinson's scientists.

The Stanley Fahn Junior Faculty Award acts as a bridge to ensure promising early-career scientists stay in the Parkinson’s research field, helping us solve, treat, and end the disease. In today’s funding environment, as young scientists navigate the path from mentored to independent research, they face a “valley of death” between their scientific potential and the funding they need to make it happen.

This award strives to avert Parkinson’s research talent loss. In conjunction with their institution’s commitment, the award gives junior investigators the support they need to secure their independent funding source (such as an NIH R01) and stay in the PD field. Becoming a career-long independent research leader in PD is the ultimate goal.

The Parkinson’s Foundation seeks clinical, pre-clinical, or basic research proposals from promising early-career scientists that will directly impact the understanding of PD. Successful projects should include novel PD research hypotheses and be inventive in methodology or approach. Each award provides $300,000 in total costs, including up to 10% of indirect costs.

Applicant salary support, up to 40% of the total salary, is permitted. The funds are awarded over three years, subject to annual progress reviews. Submission of an NIH R01 or equivalent on a PD-related project is a required award milestone at the end of year two, and the third year of funding is contingent upon this.

Eligibility and Restrictions Junior faculty possessing a PhD, MD, or equivalent are eligible to apply. Applicants must meet the National Institutes of Health (NIH) definition of a "new investigator." The Parkinson’s Foundation anticipates the typical applicant will hold an assistant professor level position.

We will consider earlier stage faculty and those with more experience provided they meet the above eligibility criteria. Applicants from Parkinson’s Foundation research centers are eligible to apply. We require a letter of support from the applicant’s department chair to demonstrate the institutional commitment to the applicant.

We restrict this program to applicants, regardless of citizenship, who are residents and faculty members at institutions in the U.S. and Canada, with a current instructor or assistant professor post. As a career development initiative, the program is not open to current or prior holders of NIH R01 awards or their equivalent.

Applicants must be in a tenure-track position, or if an instructor, must have the intent to begin a tenure-track position by the award start date as confirmed by a support letter from their department chair. Only one award will be granted per institution each year, though special exceptions may be considered. Awardees may not concurrently hold an award from another source with overlapping specific aims.

Applications from groups that have been historically underrepresented or excluded in the scientific workforce, including but not limited to racial and ethnic groups, sexual orientation and gender identities, individuals with mental/physical disabilities, and those from economically disadvantaged backgrounds, are especially encouraged. We encourage proposals from all areas of Parkinson's disease research.

The application process is highly competitive. To make the process more efficient for both applicants and reviewers, the application is in two steps. The first step is a Letter of Intent (LOI).

The Parkinson's Foundation will only consider applicants who submit complete LOIs by the specified deadline. If selected after peer review, the applicant will be invited to submit a full-length proposal. An applicant may apply to only one program per funding cycle.

In addition, an applicant may not submit multiple LOIs (with different projects) to the same program during the same funding cycle. Applications from multiple individuals within the same institution are permitted, but only one per institution may be awarded.

All components of the application must be submitted online through the Foundation's grant portal, ProposalCentral, where the LOI guidelines and the list of required components can be found ( Apply Now ). All great ideas in science begin with a seed that, when nurtured, can profoundly impact the community. However, without adequate funding, these ideas may never get started, grow, or be fully explored.

Recognizing this, the Parkinson's Foundation supports innovative projects from their inception, providing the necessary resources to maximize their impact on the Parkinson's community. The science underlying the Parkinson's Foundation Impact Award projects should be "outside the box" with the goal of bringing new light to the biology of Parkinson’s disease (PD), a new approach to PD research, or testing a truly novel therapeutic idea.

Projects should be based on groundbreaking or unconventional ideas that are unlikely to be funded through more traditional funding mechanisms. Our goal is to provide the support that will enable researchers to test new ideas with an impact on the PD community and generate compelling results that will facilitate continued investment from the Parkinson’s Foundation and other funders.

Both established researchers and newcomers to PD research are encouraged to apply. Each award provides $200,000 in total costs over 2 years ($100,000 per year). Up to 10% ($10,000 per year) of the total award may be used for indirect costs.

The Principal Investigator (PI), Co-Principal Investigator (Co-PI), and Co-Investigator (Co-I) combined salary support is capped at $35,000 annually. Salaries for the postdoctoral fellows, graduate students, and other key personnel are not capped. Tuition is not an eligible expense for any of the Foundation’s awards.

The funds are awarded over two years, subject to annual progress reviews. Eligibility and Restrictions This award is open to scientists with a PhD or MD, regardless of nationality or location. The Parkinson's Foundation Impact Awards are intended for researchers both established and new to the field of PD.

Only independent investigators are eligible to serve as PIs - applicants must hold a tenure-track position or equivalent. Non-tenure track faculty may serve as Co-PIs, and postdoctoral fellows are eligible to serve as Co-Is. Applications from Instructors will be considered if they can demonstrate that they will begin a tenure-track position by the award start date (as confirmed by a support letter from their department chair).

The Foundation reserves the sole authority to determine an applicant’s eligibility. Awardees may not concurrently hold an award from another source with overlapping specific aims. All research proposals must demonstrate a significant research focus and impact on Parkinson’s disease.

We will consider proposals seeking to: Bring new light to the biology of PD: Research that enhances our understanding of the underlying mechanisms of PD. Address an unmet need in PD research. Projects that tackle gaps or unresolved issues in the current PD research landscape.

Test a new approach (methods or technology) to Parkinson’s research: Innovative methods or technologies that could advance PD research. Identify new PD biomarkers: Discovery of novel biomarkers that can aid in the diagnosis or monitoring of PD. Identify new intervention targets: Research aimed at finding new targets for therapeutic interventions.

Test a truly novel therapeutic idea (pharmacological, brain stimulation, cell or gene therapy): Proposals that explore groundbreaking therapeutic concepts or techniques. Understand the role of co-pathologies in PD: Investigations into how co-existing conditions affect the progression or treatment of PD. Use human subjects with already established cohorts: Studies that utilize existing cohorts of human subjects to advance PD research.

Though important, the following areas are not within the scope of this award and will not be considered: Complementary and supportive therapies: Research focusing on diet, exercise, physical therapy, occupational therapy, speech therapy, psychotherapy, social work, and community support. Clinical trials: Proposals centered on clinical trial methodologies or conducting clinical trials.

Proposals whose scope does not fit the time frame of this award (24 months): Proposals that cannot be completed within the specified time frame. Want to use human subjects but don’t have established cohorts: Proposals that intend to use human subjects but lack established cohorts. Meta-analysis of existing clinical studies: Research that involves analyzing data from existing clinical studies rather than generating new primary data.

If you have questions about whether your proposal is eligible for the Impact Award RFA, please contact the Parkinson’s Foundation's Research Grants Team ( Grants@Parkinson. org ).

Applications from groups that have been historically underrepresented or excluded in the scientific workforce, including but not limited to racial and ethnic groups, sexual orientation and gender identities, individuals with mental/physical disabilities, and those from economically disadvantaged backgrounds, are especially encouraged.

The application process is highly competitive and divided into two steps to make it more efficient for both applicants and reviewers. The first step is a Letter of Intent (LOI) that is approximately 1 page long. The Parkinson's Foundation will only consider applicants who submit complete LOIs by the specified deadline.

If selected after peer review, the applicant will be invited to submit a full-length proposal. An applicant may apply to only one program per funding cycle. In addition, an applicant may not submit multiple LOIs (with different projects) to the same program during the same funding cycle.

For current application dates visit Award Deadlines . All components of the application must be submitted online through the Foundation's grant portal, ProposalCentral, where additional documents and details regarding the application process, including the LOI guidelines and the list of required components can be found ( Apply Now ). Please contact Grants@Parkinson.

org with any additional questions regarding this award. In addition, our website provides more information about the Foundation, our SAB members, peer reviewers, and previously funded grants. All submitted LOIs are subject to internal review by the Foundation’s administrative and scientific staff.

LOIs that are most strongly focused on PD research and best aligned with both the goals of the funding program and the Foundation’s mission will be selected for external peer review. The peer review results will inform decisions about which LOIs will be invited to submit a full proposal. Full proposals are subject to external peer review.

They will be competitively ranked based on the potential impact of the proposed research on Parkinson's disease, scientific merit, the qualifications of the applicant, and alignment with the Foundation's mission. Final funding decisions are expected in June. The Foundation's funding year typically begins August 1 and ends July 31 of the following year.

Conference Awards support the gathering of experts in the field working to address unsolved clinical or basic science problems relevant to Parkinson's disease. All applications should demonstrate the potential to advance the field of Parkinson's research. We require publicly available meeting results.

Applicants may use this award to: Identify or define emerging research questions Plan or organize a clinical trial Standardize research methods The Parkinson's Foundation commits to including the perspective and experience of people living with PD in the research process. We highly encourage applicants to incorporate a community engagement component into award applications.

The level of support will be determined after reviewing the application, based on the conference's potential impact on Parkinson’s research and its alignment with the Foundation’s mission. We also encourage contributions from multiple funding partners, including the applicant institution.

Eligibility and Restrictions Conference Awards are open to both national and international independent investigators with a PhD, or MD, or equivalent degree. We encourage planned or proposed funding partners but require them to be named in advance. If one or more of the proposed funding partners is a for-profit entity, e.g., a pharmaceutical company, the source must make its support in the form of an unrestricted educational award.

Conference results must be publicly available. Conferences may not be for social or networking purposes. The Parkinson's Foundation expects that each meeting or conference will engage members of the Parkinson's community.

The application period is open year-round. We accept applications anytime, though applicants must submit them at least 90 days prior to the proposed conference start date. Please contact Grants@Parkinson.

org if you are interested in applying. We review all Conference Award proposals, based on scientific merit and PD impact. We make final decisions four to six weeks after application submissions.

Funding may commence immediately upon award notification. Reporting Requirements and Other Terms We require applicants who successfully receive Parkinson's Foundation funding for their conference to identify the foundation as a support source in all conference materials and advertisements, in all presentations and any subsequent publications.

As conference sponsors, we require as-needed, complimentary registration for Parkinson's Foundation designated staff or guests. As part of the Parkinson's Foundation's public-sharing goal, we may post conference-related information, such as the notice or agenda on our website. At a minimum, awardees are required to submit a 200-word lay summary after the conference.

Explore All Our Research Grants Visit our Award Search Database for all currently and previously funded Parkinson’s Foundation research awards. Search by keyword, investigator, institution, and more!

Neuro Talk: Top 3 Parkinson’s Disease Research Areas We Fund Episode 45: Patient Engagement in Research: The Parkinson’s Advocates in Research Program (PAIR) Women and Parkinson's Research and Care Agenda Parkinson’s Foundation Research Advocates Influence Parkinson’s Funding Find Out What Our Researchers Are Working on Right Now Neuro Talk: How Does Basic Research Get Us Closer to a Cure?

Send me communications from my local chapter - Select - Alabama Alaska American Samoa Arizona Arkansas Armed Forces (Canada, Europe, Africa, or Middle East) Armed Forces Americas Armed Forces Pacific California Colorado Connecticut Delaware District of Columbia Federated States of Micronesia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Marshall Islands Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Northern Mariana Islands Ohio Oklahoma Oregon Palau Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Nova Scotia Northwest Territories Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon What is your Parkinson's connection?

Please select response Person with PD Spouse/Partner Parent has / had PD Other family of person with PD Friend of person with PD Healthcare Professional Other Are you involved with the person with Parkinson's care?

Please select response Yes No Please share the year of Parkinson's diagnosis: Country Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua & Barbuda Argentina Armenia Aruba Ascension Island Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia & Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Canary Islands Cape Verde Caribbean Netherlands Cayman Islands Central African Republic Ceuta & Melilla Chad Chile China Christmas Island Clipperton Island Cocos (Keeling) Islands Colombia Comoros Congo - Brazzaville Congo - Kinshasa Cook Islands Costa Rica Croatia Cuba Curaçao Cyprus Czechia Côte d’Ivoire Denmark Diego Garcia Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard & McDonald Islands Honduras Hong Kong SAR China Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao SAR China Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar (Burma) Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands North Korea North Macedonia Norway Oman Outlying Oceania Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Islands Poland Portugal Puerto Rico Qatar Romania Russia Rwanda Réunion Samoa San Marino Sark Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia & South Sandwich Islands South Korea South Sudan Spain Sri Lanka St.

Barthélemy St. Helena St. Kitts & Nevis St.

Lucia St. Martin St. Pierre & Miquelon St.

Vincent & Grenadines Sudan Suriname Svalbard & Jan Mayen Sweden Switzerland Syria São Tomé & Príncipe Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad & Tobago Tristan da Cunha Tunisia Turkmenistan Turks & Caicos Islands Tuvalu Türkiye U.S. Outlying Islands U.S. Virgin Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Wallis & Futuna Western Sahara Yemen Zambia Zimbabwe Åland Islands Please select response Yes No My loved one with PD is a Veteran Which language would you prefer to hear from us in?

*Please note that not all content is available in both languages. If you are interested in receiving Spanish communications, we recommend selecting “both" to stay best informed on the Foundation's work and the latest in PD news. Please select response English Spanish Both English and Spanish How did you hear about the Parkinson's Foundation?

Please select response Parkinson's Foundation Website Parkinson's Foundation Conference, Event, or Meeting Parkinson's Foundation Email Parkinson's Foundation Helpline Parkinson's Foundation Brochure, Flyer or Postcard Parkinson's Foundation Staff Facebook/Twitter/YouTube/LinkedIn/Instagram Support Group Google AARP Friend, Family or Coworker Veterans Administration / Local Veterans Organization Doctor's office YMCA Parkinson's Foundation Moving Day Other